SABS Latest Press Releases

-- October 14, 2026 --

SAB BIO to Participate in Chardan 10th Annual Healthcare Conference Globe Newswire 8:30 AM

-- October 13, 2026 --

SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes Globe Newswire 8:30 AM

-- October 1, 2026 --

SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress Globe Newswire 8:30 AM

-- September 22, 2026 --

SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes Globe Newswire 8:30 AM

-- September 1, 2026 --

SAB BIO to Participate in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- August 6, 2026 --

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights Globe Newswire 7:30 AM

-- July 30, 2026 --

SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET Globe Newswire 8:30 AM

-- July 7, 2026 --

Breakthrough T1D Awards Grant to Support PRISE-hATG Study of SAB-142 in Stage 3 Type 1 Diabetes Globe Newswire 8:00 AM

-- May 29, 2026 --

SAB BIO to Present Data on SAB-142 at The American Diabetes Association's 2026 Scientific Sessions and FOCIS 2026 Annual Meeting Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes